This book reviews the recent literature on the impact of epilepsy on everyday experience and the methodological issues involved in assessing that impact, and considers the perspectives of a range of health professionals in this field.

Describes an approach to diagnosing and treating people with epilepsy (though not confined to this condition) with a view of the patient as an integral human being, comprising both their seizures and the psychical and social situation. This book inquires into every treatment's goals, whilst including the patients' (and their relatives') subjective evaluations and perspectives. This includes early considerations of benefits versus risks for the patient, the ultimate question being what quality of life will be attained and how much independent life and employment will be feasible. Comprehensive Care does not necessarily need to be associated with elevated cost, as many epilepsy centres have enough knowledge, imagination, and staff for this purpose, the problem being how to combine and use existing resources most effectively.

Written in response to the Supreme Court's landmark Daubert decision regarding provision of expert witness scientific testimony, Assessment of Rehabilitative and Quality of Life Issues in Litigation focuses on quality of life as a means of conceptualizing and measuring pain and suffering in the controversial enjoyment of life debate. The authors make a compelling argument for a quality of life paradigm based on a rehabilitation and health economics analysis, demonstrating that qualified rehabilitationists are the best experts to provide analyses of the impact of disability or injury on quality of life over the lifespan. The extensive literature review enables attorneys and litigation experts to easily access quality of life literature.

Epilepsy, also called seizure disorder, is a condition of the brain marked by a susceptibility to recurrent seizures. Epilepsy affects 1 per cent to 2 per cent of the population. In about half the cases of epilepsy, the cause is unknown. However, some possible causes of epilepsy include: birth trauma, perinatal infection, anoxia, infectious diseases, ingestion of toxins, tumours of the brain, inherited disorders or degenerative disease, head injury or trauma, metabolic disorders, cerebrovascular accident and alcohol withdrawal. This new book presents the latest worldwide research in this field.

Atlas of Epilepsies is a landmark, all-encompassing, illustrated reference work and hands-on guide to the diagnosis, management and treatment of epilepsy in all its forms and across all age groups. The premier text in the field with over one thousand images, the Atlas’s highly illustrative approach tackles the difficult subject of epileptic seizures and epileptic syndromes, accompanied by sequential photographs of each management step. Intraoperative photographs are accompanied by detailed figure legends describing nuances, subtleties, and the thought processes involved in each step, providing a fuller understanding of each procedure. The Atlas draws on the expertise of over 300 internationally-renowned experts, and is liberally interspersed with clinical insights and personal vignettes that offer helpful tips, technical advice and critical knowledge to the clinician and scholar. The thorough and complete table of contents includes dedicated sections or chapters on important topics such as neonatal and pediatric seizures; imitators of epilepsy; EEG and neuroimaging; psychiatric and quality of life aspects of epilepsy; and a complete guide to treatment options including current and up-to-date chapters on pharmaceuticals, surgical procedures, and additional and alternative treatments. No other publication addresses epilepsies as thoroughly and completely as the Atlas of Epilepsies. Exhaustive and illustrative, convenient and current, this reference is sure to be the premier text on epilepsy for many years to come.

"Rating scales are used daily by everyone involved in the management of patients with neurologic disease and in the design and management of neurologic clinical trials. Now there is a single source for the wide range of scales used in specific neurologic diseases and neurorehabilitation. You will refer to this volume constantly! The first edition of the Handbook of Neurologic Rating Scales quickly became an invaluable reference work on the increasing array of scales for measuring neurologic disease. In the brief few years since the first edition the importance of this book has only increased. New Chapters Include Scales On: Generic and general use Pediatric neurology and rehabilitation Peripheral neuropathy and pain Ataxia HIV/AIDS And instruments for diagnosing headaches. Formal measurement of the effects of neurologic disease and of treatment effects, beyond the description of changes on the standard neurologic examination, is a relatively recent development. Controlled clinical trials and outcomes research are at the heart of modern information-based medicine, and neurologic scales are essential tools in clinical trials designed to provide this information. A Resource for Clinical Trials The Handbook of Neurologic Rating Scales provides a resource for clinicians and clinical investigators in the broad field of neurology and neurologic rehabilitation to help them: evaluate the clinical trials literature by providing information on the scales being used evaluate and select appropriate and efficient scales for clinical trials and outcomes research, and provide information that will help them to develop new scales or measures or to improve existing ones. A Resource for Evaluating Disease Status Outcomes research is playing an increasingly important role in clinical management and neurorehabilitation, and these also depend largely on measurement of disease status and change. In this era of managed care, neurologists must produce outcomes data demonstrating the effectiveness of neurologic care if the specialty is to survive, and certainly if it is to thrive. Even effective therapies are likely to fall by the wayside if studies to prove their effectiveness are not done. Comprehensive and Standardized Information on All Scales Each chapter in this volume contains the scales of importance and in current use, including a sequence of scale descriptions and specific scales in a standard format, as well as a summary and recommendations indicating which scales are most useful for specific purposes and whether a combination of scales is particularly useful or if better scales are needed. Each entry notes: the purpose for which the scale was developed and its current uses if they differ from those for which it was developed a detailed description of the scale information about validation, such as: Does the scale have face validity? i.e., does it appear to measure what it purports to measure? how and by whom the scale is administered the time needed to administer and score the scale the scale itself or, when the scale is proprietary or too long for inclusion, a description and key references special considerations, including unusual measures needed to obtain a valid score or problems in administering the test in specific patients advantages, or what makes the scale good or useful. Disadvantages, or what makes the scale difficult to use or impairs its reliability key references, including the original publication of the scale and its validation Downloadable PDFs of the scales contained in the Handbook of Neurologic Rating Scales are included with the purchase of this book. The password to download the files can be found in the book itself.

This transcultural comparison of scientific knowledge and clinical experience provides a framework for a global health policy for epilepsy.

This book is a very provocative and interesting addition to the literature on Epilepsy. It offers a lot of appealing and stimulating work to offer food of thought to the readers from different disciplines. Around 5% of the total world population have seizures but only 0.9% is diagnosed with epilepsy, so it is very important to understand the differences between seizures and epilepsy, and also to identify the factors responsible for its etiology so as to have more effective therapeutic regime. In this book we have twenty chapters ranging from causes and underlying mechanisms to the treatment and side effects of epilepsy. This book contains a variety of chapters which will stimulate the readers to think about the complex interplay of epigenetics and epilepsy.

Advances in Epilepsy Research and Treatment: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Seizures. The editors have built Advances in Epilepsy Research and Treatment: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Seizures in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Advances in Epilepsy Research and Treatment: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.